Pathogenic mechanisms of myotonic dystrophy

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Myotonic dystrophy (DM) is a dominant genetic disorder and the most common adult muscular dystrophy, affecting 1 in 8500 globally.
• DM1 and DM2 are caused by distinct microsatellite expansions in the DMPK and ZNF9 genes, respectively.
• The disease mechanism involves toxic RNA transcripts with expanded CUG or CCUG repeats.

Purpose of the Study:

• To review the RNA gain-of-function disease mechanism in DM1.
• To highlight the critical roles of MBNL1 and CUGBP1 RNA-binding proteins in DM1 pathogenesis.
• To discuss the relevance of these findings to other RNA dominant disorders.

Main Methods:

• This review synthesizes existing research on the molecular mechanisms of DM1.
• Focuses on the interplay between expanded repeat RNA and specific RNA-binding proteins.
• Examines downstream consequences on gene regulation.

Main Results:

• Expanded repeat RNA sequesters MBNL1, leading to its loss-of-function.
• CUGBP1 protein levels are upregulated, contributing to disease pathology.
• Dysregulated alternative splicing, mRNA translation, and stability are key downstream effects.

Conclusions:

• The RNA gain-of-function mechanism involving MBNL1 and CUGBP1 is central to DM1.
• Understanding these interactions provides insights into DM1's complex phenotype.
• This knowledge is crucial for developing targeted therapies for DM1 and related disorders.